Comparing Factors Associated With Tubulointerstitial Inflammation in Lupus Nephritis
Routinely available serologic markers have no correlation with tubulointerstitial damage in patients with lupus nephritis.
Routinely available serologic markers have no correlation with tubulointerstitial damage in patients with lupus nephritis.
Investigators sought to evaluate changes in demographic, clinical, and histologic presentation in patients with lupus nephritis between 1970 and 2016.
Remission status was a significant and useful predictor of renal survival, in patients with lupus nephritis.
Researchers investigated serum IgG anti-MDA expression and associations with disease activity in patients with systemic lupus erythematosus.
No significant differences were observed in the incidence of ESRD and mortality among men vs women with lupus nephritis.
This week, a phase III trial for investigational drug voclosporin for lupus nephritis treatment was approved, prolonged insomnia may lead to less robust bone formation — causing osteoporosis and bone fractures — and researchers found that women who drink a moderate amount of alcohol daily have a reduced risk of developing systemic lupus erythmatosus.
Lupus nephritis a risk factor for some, but not all, cardiovascular outcomes in study of patients with SLE.
Targeted IL-6 inhibition with sirukumab did not demonstrate efficacy or acceptable safety in patients with active lupus nephritis concomitantly receiving immunosupprsant therapy.
Researchers found significant disparities in pregnancy complications rates and hospitalization costs among white, black, and Hispanic women with systemic lupus erythematosus
Panels of urinary biomarkers were shown to be have increased diagnostic power in predicting complete clinical responses when compared with individual biomarkers.